ReviewValproate and neuroprotection
References (72)
Neuroprotection and neurodegenerative disease
J Clin Neurosci
(2002)Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action
Prog Neurobiol
(1999)Preventing post-traumatic epilepsy after brain injury: weighing the costs and benefits of anticonvulsant prophylaxis
Trends Pharmacol Sci
(1997)Why and when are seizures bad for the brain?
Trends Pharmacol Sci
(2001)GABA and mood disorders: a brief review and hypothesis
J Affect Disord
(1995)- et al.
Valproic acid differs in its in vitro effect on glutamic acid decarboxylase activity in neonatal and adult rat brain
Gen Pharmacol
(1996) - et al.
Drug-induced changes in GABA content of nerve endings in 11 rat brain regions: correlation to pharmacological effects
Neurosci Lett
(1984) - et al.
Effects of valproic acid on H-diazepam and H-dihydropicrotoxin in binding sites at the benzodiazepine-GABA receptor-ionophore complex
Brain Res
(1981) - et al.
Anticonvulsant drug effects on spontaneous thalamocortical rhythms in vitro: valproic acid, clonazepam, and α-methyl-α-phenylsuccinimide
Epilepsy Res
(1996) - et al.
Valproate suppresses N-methyl-D-aspartate evoked, transient depolarisations in the rat neocortex in vitro
Brain Res
(1991)
Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices
Brain Res Bull
(1994)
The action of valproate on spontaneous epileptiform activity in the absence of synaptic transmission on evoked changes in [Ca++] and [K+] in the hippocampal slice
Brain Res
(1986)
Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness
Biol Psychiatry
(2000)
Lithium-induced increase in human brain grey matter
Lancet
(2000)
Tetraspan protein CD151: a common target of mood stabilizing drugs?
Neuropsychopharmacology
(2001)
A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency
Neurosci Lett
(2000)
B. Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus
Biol Psychiatry
(2000)
N-acetylaspartate in neuropsychiatric disorders
Prog Neurobiol
(1995)
Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease
Int J Devl Neurosci
(1998)
Anticonvulsants attenuate amyloid β-peptide neurotoxicity, Ca2+ deregulation and cytoskeletal pathology
Neurobiol Aging
(1995)
Valproate in the treatment of partial epilepsies
Epilepsia
(1994)
Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness
ANZ J Psych
(1999)
Genetic classification of primary neurodegenerative diseases
Science
(1998)
Chromosomal abnormalities in epilepsy: a review for clinicians and gene hunters
Epilepsia
(2001)
Does antiepileptic drug therapy prevent the development of ‘chronic’ epilepsy?
Epilepsia
(1996)
Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy
Ann Neurol
(1991)
Can anticonvulsant drug therapy ‘cure’ epilepsy?
CNS Drugs
(2001)
Neurology
(1993)
Epilepsy in Iceland. A clinical and epidemiological investigation
Acta Neurol Scand
(1966)
Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta analysis of controlled trials
Epilepsia
(2001)
More evidence for seizure-induced neuron loss: is hippocampal sclerosis both cause and effect of epilepsy?
Neurology
(2001)
Volumetric MRI, pathological, and neuropsychological progression in hippocampal sclerosis
Neurology
(2001)
Hippocampal sclerosis following brief generalised seizures in adulthood
Neurology
(2001)
Prolonged febrile convulsions and medial temporal lobe epilepsy in an identical twin
Neurology
(2001)
Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate
J Neurochem
(2001)
Cited by (0)
- f1
Correspondence to: Professor F. J. E. Vajda, Australian Centre for Clinical Neuropharmacology – Raoul Wallenberg Centre, University of Melbourne and St Vincent's Hospital, Victoria Parade, Fitzroy, Vic 3056, Australia. Tel: +61-3-9288-3527; E-mail address: [email protected] (F. J. E. Vajda).
Copyright © 2002 Elsevier Science Ltd. All rights reserved.